RA CAPITAL MANAGEMENT, L.P. Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$5.1T
Holdings
57
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (57 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 4,914,955 | $726.9B | 14.16% | |
| 2 | —FORMA THERAPEUTICS HLDGS INC | 9,011,651 | $419.0B | 8.16% | |
| 3 | NVV1NOVAVAX INC | 4,758,833 | $396.6B | 7.73% | |
| 4 | CCXIEURCHEMOCENTRYX INC | 4,826,910 | $277.7B | 5.41% | |
| 5 | TGTXTG THERAPEUTICS INC | 12,788,457 | $249.1B | 4.85% | |
| 6 | PCVXVAXCYTE INC | 5,489,181 | $173.5B | 3.38% | |
| 7 | AXSMAXSOME THERAPEUTICS INC | 2,035,132 | $167.5B | 3.26% | |
| 8 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 7,801,641 | $162.9B | 3.17% | |
| 9 | —SATSUMA PHARMACEUTICALS INC | 4,681,858 | $134.7B | 2.62% | |
| 10 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 13,052,464 | $130.7B | 2.55% | |
| 11 | MGNXMACROGENICS INC | 4,584,652 | $128.0B | 2.49% | |
| 12 | PHATPHATHOM PHARMACEUTICALS INC | 3,825,008 | $125.9B | 2.45% | |
| 13 | ARVNARVINAS INC | 3,672,872 | $123.2B | 2.40% | |
| 14 | RYTMRHYTHM PHARMACEUTICALS INC | 5,210,088 | $116.2B | 2.26% | |
| 15 | KALAKALA PHARMACEUTICALS INC | 10,874,613 | $114.3B | 2.23% | |
| 16 | BDTXBLACK DIAMOND THERAPEUTICS INC | 2,589,904 | $109.2B | 2.13% | |
| 17 | LEGNLEGEND BIOTECH CORP | 2,481,942 | $105.6B | 2.06% | |
| 18 | —EIDOS THERAPEUTICS INC | 2,162,671 | $103.1B | 2.01% | |
| 19 | ALECALECTOR INC | 4,127,348 | $100.9B | 1.97% | |
| 20 | —ZOGENIX INC | 3,677,424 | $99.3B | 1.94% | |
| 21 | —RETROPHIN INC | 4,635,687 | $94.6B | 1.84% | |
| 22 | —MOMENTA PHARMACEUTICALS INC | 2,531,445 | $84.2B | 1.64% | |
| 23 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $80.9B | 1.58% | |
| 24 | 1K0IGM BIOSCIENCES INC | 982,723 | $71.7B | 1.40% | |
| 25 | KROSKEROS THERAPEUTICS INC | 1,875,000 | $70.3B | 1.37% | |
| 26 | GONGERON CORP | 30,126,299 | $65.7B | 1.28% | |
| 27 | ETNBGBP89BIO INC | 3,161,214 | $63.0B | 1.23% | |
| 28 | —AKOUOS INC | 2,281,249 | $51.3B | 1.00% | |
| 29 | TREURTRILLIUM THERAPEUTICS INC | 6,162,694 | $49.9B | 0.97% | |
| 30 | ORTXUSDORCHARD THERAPEUTICS PLC | 10,403,187 | $45.7B | 0.89% | |
| 31 | ARDXARDELYX INC | 6,260,904 | $43.3B | 0.84% | |
| 32 | CRNXCRINETICS PHARMACEUTICALS INC | 2,328,698 | $40.8B | 0.80% | |
| 33 | RLMDRELMADA THERAPEUTICS INC | 851,907 | $38.1B | 0.74% | |
| 34 | —PREVAIL THERAPEUTICS INC | 2,494,691 | $37.2B | 0.72% | |
| 35 | ARQTARCUTIS BIOTHERAPEUTICS INC | 1,165,184 | $35.2B | 0.69% | |
| 36 | STOKSTOKE THERAPEUTICS INC | 1,119,963 | $26.7B | 0.52% | |
| 37 | SCPHSCPHARMACEUTICALS INC | 3,518,998 | $25.9B | 0.50% | |
| 38 | AVDLAVADEL PHARMACEUTICALS PLC | 3,126,131 | $25.3B | 0.49% | |
| 39 | —IMARA INC | 829,348 | $22.9B | 0.45% | |
| 40 | OCULOCULAR THERAPEUTIX INC | 2,727,272 | $22.7B | 0.44% | |
| 41 | LRMRLARIMAR THERAPEUTICS INC | 1,515,151 | $19.5B | 0.38% | |
| 42 | CNCEEURCONCERT PHARMACEUTICALS INC | 1,858,474 | $18.5B | 0.36% | |
| 43 | VSTMVERASTEM INC | 9,129,251 | $15.7B | 0.31% | |
| 44 | SNDXSYNDAX PHARMACEUTICALS INC | 1,023,067 | $15.2B | 0.30% | |
| 45 | TCE2CELLDEX THERAPEUTICS INC NEW | 1,150,000 | $14.9B | 0.29% | |
| 46 | STROSUTRO BIOPHARMA INC | 1,919,644 | $14.9B | 0.29% | |
| 47 | SLDBSOLID BIOSCIENCES INC | 4,571,164 | $13.4B | 0.26% | |
| 48 | RPTXREPARE THERAPEUTICS INC | 409,000 | $12.7B | 0.25% | |
| 49 | LYRALYRA THERAPEUTICS INC | 815,849 | $9.3B | 0.18% | |
| 50 | PASGPASSAGE BIO INC | 322,630 | $8.8B | 0.17% | |
| 51 | —ARYA SCIENCES ACQUISITION CORP | 700,000 | $8.1B | 0.16% | |
| 52 | GRTXGALERA THERAPEUTICS INC | 825,118 | $5.9B | 0.11% | |
| 53 | EPIEURESSA PHARMA INC | 849,300 | $5.3B | 0.10% | |
| 54 | ASNSUSDX4 PHARMACEUTICALS INC | 559,494 | $5.2B | 0.10% | |
| 55 | IM8NINSMED INC | 87,405 | $2.4B | 0.05% | |
| 56 | OVIDOVID THERAPEUTICS INC | 285,000 | $2.1B | 0.04% | |
| 57 | SELBUSDSELECTA BIOSCIENCES INC | 95,000 | $270.0M | 0.01% |